The 2017 SATVI Annual Report is now available.
Researchers at the South African Tuberculosis Vaccine Initiative have co-authored an article titled "Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.
The South African Tuberculosis Vaccine Initiative invites applications for a Postdoctoral Fellowship to conduct research on the Immunology of TB vaccines. Closing date 15 May 2018.
SATVI researchers have published an article titled: "Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial" appearing in the latest Lancet Respiratory Medicine.